Form 4 for CMMB Chemomab Therapeutics Ltd.

Accepted 2022-06-21 00:00:00 ET · period of report 2022-03-16 · accession 0001178913-22-002402 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-06-21	2022-03-16	CMMB	Marvin Donald	CFO, COO, Executive VP	P - Purchase	$3.27	+500	2,000	+33%	+$1,638
D	2022-06-21	2021-11-08	CMMB	Marvin Donald	CFO, COO, Executive VP	A - Grant	$0.00	+196.9K	196.9K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	American Depositary Shares	2022-03-16	P	A	250	$3.30	1,750	D	—	—	(F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
2	Common	American Depositary Shares	2022-03-16	P	A	250	$3.25	2,000	D	—	—	(F1) Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
3	Derivative	Option to Purchase American Depositary Shares	2021-11-08	A	A	196,875	$0.00	196,875	D	$9.77 · — to 2021-11-08	196,875 American Depositary Shares	(F2) No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. (F3) The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.